Officials in Canada said on 25 February 2021 that Canada's COVID-19 vaccination campaign is ramping up after earlier supply disruptions, Reuters news agency reported on Friday.
Canada's deputy chief public health officer, Howard Njoo, was quoted as telling a briefing that over 240,000 COVID-19 doses were injected last week, the most in more than a month.
"We are seeing positive signs that the rollout is ramping up. ... This is a reflection of greater supply," he said, adding that about 2.9% of Canadians had received at least one dose and this percentage is expected to significantly increase throughout March 2021.
Major General Dany Fortin, in charge of coordinating the COVID-19 vaccine rollout, has said a total of 643,000 doses had been distributed this week, the highest amount yet.
Reportedly, Canada has deals with US pharmaceutical companies Pfizer Inc and Moderna Inc to purchase COVID-19 vaccines, but both companies ran into production problems last month and reduced shipments.
Canada says it is still on track to receive a total of six million doses from Pfizer and Moderna by the end of March 2021 and that anyone who wants a shot can get one by the end of September 2021.
So far, Canada has recorded a total of 21,807 COVID-19 deaths and 855,126 cases.
FDA grants priority review for GSK's gepotidacin gonorrhoea indication
GSK to receive USD370m and future royalties in CureVac/BioNTech settlement
FDA lifts pause on Valneva's chikungunya vaccine IXCHIQ for elderly, updates prescribing information
Anixa Biosciences begins US FDA approved IND transfer to support Phase 2 breast cancer vaccine trial
Pfizer and BioNTech receive EU regulatory backing for LP.8.1-adapted COVID-19 vaccine
Sanofi to acquire Vicebio for USD1.15bn to strengthen respiratory vaccine pipeline
Bavarian Nordic chikungunya vaccine enters Health Canada review process
SK bioscience submits IND for Phase 1/2 clinical trial of new influenza vaccine candidate
GC Biopharma secures Vietnamese approval for varicella vaccine BARYCELA
GSK announces submission of RSV vaccine Arexvy for FDA review
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Centivax raises USD45m to commercialise universal flu vaccine
CyanVac's nasal COVID vaccine shows promise in phase 1 trial
hVIVO supports Cidara Therapeutics' positive Phase 2b influenza study results